New Screening Coverage Will Boost GI-Endoscopy Market

Comments
Print

WALTHAM, Mass.—According to Millennium Research Group (MRG), a global medical-technology-market research association, the Patient Protection and Affordable Care Act of 2010 will make colorectal cancer screening a possibility for many more Americans than before. These reimbursement changes will lead to a growing number of colorectal cancer screening procedures through 2014, and will drive sales of many gastrointestinal endoscopy devices, according to the report.

Under the healthcare act, all new health insurance policies must cover preventative exams, including colonoscopies, without charging out-of-pocket fees such as copayments or deductibles. All Medicare patients will therefore have colorectal cancer screening colonoscopies fully covered as of Jan. 1, 2011. This expanded coverage of colorectal cancer screening procedures will increase the number of colonoscopies performed over the next five years. Sales of devices used in the procedures, such as colonoscopes and biopsy forceps, will also rise to meet this growing demand for colorectal cancer screening. Although colonoscopy volumes dipped in 2009 during the recession, they are climbing again and will continue to rise as increased medical insurance coverage encourages more Americans to undergo screening.

"At the height of the economic downturn, many Americans declined to undergo colorectal cancer screening because they lost insurance coverage for it or they felt that paying for a diagnostic procedure when they did not have any symptoms was not a priority for them in economically uncertain times," said Sara Scharf, PhD, analyst at MRG. "As this new coverage is put in place, patients will increasingly get screened for colorectal cancer."

MRG's new report, US Markets for Gastrointestinal Endoscopy Devices 2010, now includes more segments, detailed competitor coverage, and insights into trends than ever before. The report provides a thorough analysis of procedural trending, emerging markets, competing and complementary procedures, and revenue growth for the major gastrointestinal endoscopy devices in the US, including videoscopes, enteral feeding devices, endoscopic retrograde cholangiopancreatography devices, hemostasis devices, biopsy forceps, stents, virtual colonoscopy systems, esophageal dilation balloons, capsule endoscopes, polypectomy snares, and retrieval devices. For the first time, this report includes market analyses of enteral feeding giving sets, nasogastric tubes, colonic and duodenal stents, and Barrett's esophagus ablation devices. 

Source: MRG

Comments
comments powered by Disqus